Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;13(1):29-37.
doi: 10.1080/13550280601103125.

Influenza A virus transactivates the mouse envelope gene encoding syncytin B and its regulator, glial cells missing 1

Affiliations

Influenza A virus transactivates the mouse envelope gene encoding syncytin B and its regulator, glial cells missing 1

Linnéa Asp et al. J Neurovirol. 2007.

Abstract

Recently, two candidate analogs for human syncytin, denoted syncytins A and B, were identified in the murine genome. These were found to have expression patterns and functions similar to human syncytin. In addition, the identification of glial cells missing (GCM)-binding motifs in putative promoter regions of the mouse syncytins imply analogous regulation. Transcriptional modulation of syncytin by exogenous agents was recently suggested by studies reporting transactivation of syncytin in human cell lines following virus infections. The authors report that influenza A virus infection increased the levels of transcripts encoding Gcm1 and syncytin B, but not syncytin A, in NIH-3T3 cells as well as in mouse primary neurons or glia. Overexpression of human GCM1 in NIH-3T3 cells resulted in increased levels of transcripts encoding syncytin B but not syncytin A. Systemic administration of neurotropic influenza A virus resulted in a neuronal infection and increased levels of Gcm1-encoding transcripts in brains of young mice. The mouse may therefore be useful for studies on the expression and function of endogenous retroviral envelope genes and transcription factors regulating their expression in the placenta and brain during physiological or pathological conditions.

PubMed Disclaimer

References

    1. J Neurovirol. 2001 Apr;7(2):117-24 - PubMed
    1. Lab Invest. 1983 Dec;49(6):686-92 - PubMed
    1. Nat Neurosci. 2004 Oct;7(10):1088-95 - PubMed
    1. J Virol. 2000 Apr;74(7):3321-9 - PubMed
    1. Development. 2003 Dec;130(24):6027-35 - PubMed

Publication types

LinkOut - more resources